ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 50 filers reported holding ODONATE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $269,000 | -99.4% | 20,007 | -98.1% | 0.00% | -100.0% |
| Q2 2020 | $41,435,000 | +29.3% | 1,065,182 | -8.2% | 0.02% | 0.0% |
| Q1 2020 | $32,053,000 | -17.0% | 1,160,932 | -2.4% | 0.02% | +5.0% |
| Q4 2019 | $38,614,000 | +18.8% | 1,189,958 | -4.7% | 0.02% | +11.1% |
| Q3 2019 | $32,516,000 | -40.4% | 1,249,203 | -16.0% | 0.02% | -37.9% |
| Q2 2019 | $54,581,000 | +57.9% | 1,487,636 | -4.8% | 0.03% | +52.6% |
| Q1 2019 | $34,558,000 | +53.3% | 1,562,995 | -2.4% | 0.02% | +35.7% |
| Q4 2018 | $22,545,000 | -27.5% | 1,601,213 | -0.0% | 0.01% | -6.7% |
| Q3 2018 | $31,091,000 | -12.1% | 1,601,786 | -0.0% | 0.02% | -16.7% |
| Q2 2018 | $35,373,000 | +7.7% | 1,602,018 | +1.5% | 0.02% | +5.9% |
| Q1 2018 | $32,841,000 | -14.6% | 1,578,427 | +0.0% | 0.02% | -5.6% |
| Q4 2017 | $38,437,000 | – | 1,577,927 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $53,060,000 | 14.93% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $1,710,000 | 0.93% |
| Boxer Capital, LLC | 5,607,086 | $19,176,000 | 0.65% |
| Samsara BioCapital, LLC | 700,421 | $2,395,000 | 0.44% |
| SABBY MANAGEMENT, LLC | 634,728 | $2,171,000 | 0.42% |
| Prosight Management, LP | 117,621 | $402,000 | 0.33% |
| QCM Cayman, Ltd. | 15,478 | $53,000 | 0.16% |
| Ikarian Capital, LLC | 1,336,412 | $4,571,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 169,198 | $579,000 | 0.13% |
| Walleye Capital LLC | 273,000 | $934,000 | 0.05% |